Cargando…

Intractable hyperkalemia due to nicorandil induced potassium channel syndrome

Nicorandil is a commonly used antianginal agent, which has both nitrate-like and ATP-sensitive potassium (K(ATP)) channel activator properties. Activation of potassium channels by nicorandil causes expulsion of potassium ions into the extracellular space leading to membrane hyperpolarization, closur...

Descripción completa

Detalles Bibliográficos
Autores principales: Chowdhry, Vivek, Mohanty, B. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900302/
https://www.ncbi.nlm.nih.gov/pubmed/25566721
http://dx.doi.org/10.4103/0971-9784.148331
_version_ 1782436605914513408
author Chowdhry, Vivek
Mohanty, B. B.
author_facet Chowdhry, Vivek
Mohanty, B. B.
author_sort Chowdhry, Vivek
collection PubMed
description Nicorandil is a commonly used antianginal agent, which has both nitrate-like and ATP-sensitive potassium (K(ATP)) channel activator properties. Activation of potassium channels by nicorandil causes expulsion of potassium ions into the extracellular space leading to membrane hyperpolarization, closure of voltage-gated calcium channels and finally vasodilatation. However, on the other hand, being an activator of K(ATP) channel, it can expel K(+) ions out of the cells and can cause hyperkalemia. Here, we report a case of nicorandil induced hyperkalemia unresponsive to medical treatment in a patient with diabetic nephropathy.
format Online
Article
Text
id pubmed-4900302
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-49003022016-06-16 Intractable hyperkalemia due to nicorandil induced potassium channel syndrome Chowdhry, Vivek Mohanty, B. B. Ann Card Anaesth Case Report Nicorandil is a commonly used antianginal agent, which has both nitrate-like and ATP-sensitive potassium (K(ATP)) channel activator properties. Activation of potassium channels by nicorandil causes expulsion of potassium ions into the extracellular space leading to membrane hyperpolarization, closure of voltage-gated calcium channels and finally vasodilatation. However, on the other hand, being an activator of K(ATP) channel, it can expel K(+) ions out of the cells and can cause hyperkalemia. Here, we report a case of nicorandil induced hyperkalemia unresponsive to medical treatment in a patient with diabetic nephropathy. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4900302/ /pubmed/25566721 http://dx.doi.org/10.4103/0971-9784.148331 Text en Copyright: © 2015 Annals of Cardiac Anaesthesia http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Case Report
Chowdhry, Vivek
Mohanty, B. B.
Intractable hyperkalemia due to nicorandil induced potassium channel syndrome
title Intractable hyperkalemia due to nicorandil induced potassium channel syndrome
title_full Intractable hyperkalemia due to nicorandil induced potassium channel syndrome
title_fullStr Intractable hyperkalemia due to nicorandil induced potassium channel syndrome
title_full_unstemmed Intractable hyperkalemia due to nicorandil induced potassium channel syndrome
title_short Intractable hyperkalemia due to nicorandil induced potassium channel syndrome
title_sort intractable hyperkalemia due to nicorandil induced potassium channel syndrome
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900302/
https://www.ncbi.nlm.nih.gov/pubmed/25566721
http://dx.doi.org/10.4103/0971-9784.148331
work_keys_str_mv AT chowdhryvivek intractablehyperkalemiaduetonicorandilinducedpotassiumchannelsyndrome
AT mohantybb intractablehyperkalemiaduetonicorandilinducedpotassiumchannelsyndrome